The estimated Net Worth of Branislav Vajdic is at least $2.13 Milion dollars as of 10 February 2023. Dr Vajdic owns over 1,287 units of HeartBeam Inc stock worth over $2,050,630 and over the last 3 years he sold BEAT stock worth over $0. In addition, he makes $81,856 as Founder i CEO & Director at HeartBeam Inc.
Dr has made over 2 trades of the HeartBeam Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 1,287 units of BEAT stock worth $2,896 on 10 February 2023.
The largest trade he's ever made was exercising 115,559 units of HeartBeam Inc stock on 11 November 2021 worth over $485,348. On average, Dr trades about 16,692 units every 65 days since 2021. As of 10 February 2023 he still owns at least 911,391 units of HeartBeam Inc stock.
You can see the complete history of Dr Vajdic stock trades at the bottom of the page.
Dr. Branislav Vajdic Ph.D. is the Founder, CEO & Director at HeartBeam Inc.
As the Founder i CEO & Director of HeartBeam Inc, the total compensation of Dr D at HeartBeam Inc is $81,856. There are 13 executives at HeartBeam Inc getting paid more, with Joseph Capper having the highest compensation of $4,133,160.
Dr D is 66, he's been the Founder i CEO & Director of HeartBeam Inc since . There are 7 older and 10 younger executives at HeartBeam Inc. The oldest executive at HeartBeam Inc is Robert Rubin, 74, who is the Independent Director.
Branislav's mailing address filed with the SEC is C/O HEARTBEAM, INC.,, 2118 WALSH AVENUE, SUITE 210, SANTA CLARA, CA, 95050.
Over the last 11 years, insiders at HeartBeam Inc have traded over $23,124,978 worth of HeartBeam Inc stock and bought 31,500 units worth $221,145 . The most active insiders traders include Joseph H Capper, Heather C Getz oraz Willem Elfrink. On average, HeartBeam Inc executives and independent directors trade stock every 32 days with the average trade being worth of $55,046. The most recent stock trade was executed by Urioste George De on 6 September 2024, trading 1,674 units of BEAT stock currently worth $3,917.
heartbeam developed a mhealth technology that is diagnostically equivalent to a cardiologist reading a patient’s 12 lead ecg and examining the patient. it comprises a credit card size, 12 lead equivalent, ecg device and a cloud-based diagnostic expert system. studies designed by harvard medical school faculty have shown heartbeam performance to be equal or better than world class cardiologists in diagnosing a heart attack. the technology features personalized diagnostic thresholds and novel heart attack ecg markers from which the application can also help cardiologists locate a heart attack on a 3d model of the heart. heartbeam's icardiologist application utilizes artificial intelligence / machine learning to drive continuous improvements of the system's ability to provide patient analysis and improve the solution's predictive properties.
HeartBeam Inc executives and other stock owners filed with the SEC include: